XML 29 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Retain earnings
Retain earnings
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period at Dec. 31, 2020 $ 709,525   $ 16 $ 318,358   $ (801) $ 391,952  
Balance at beginning of period (in shares) at Dec. 31, 2020     16,080          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 27,745   $ 1 27,744        
Issuance of common stock under employee stock compensation plans, net (in shares)     687          
Share-based compensation 38,783     38,783        
Unrealized net gain (loss) on available-for-sale securities, net of tax (116)         (116)    
Reacquisition of equity due to 2023 debt extinguishment, net of tax (12,407)     (12,407)        
Warrant and bond hedge unwind transactions 491     491        
Net income (loss) 57,138           57,138  
Balance at end of period at Dec. 31, 2021 $ 821,159 $ (15,997) $ 17 372,969 $ (51,130) (917) 449,090 $ 35,133
Balance at end of period (in shares) at Dec. 31, 2021     16,767          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]              
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes $ (5,004)     (5,004)        
Issuance of common stock under employee stock compensation plans, net (in shares)     184          
Share-based compensation 60,285     60,285        
Unrealized net gain (loss) on available-for-sale securities, net of tax (67)         (67)    
Bond hedge transaction 202     202        
Distribution of OmniAb (229,732)     (229,732)        
Net income (loss) (33,361)           (33,361)  
Balance at end of period at Dec. 31, 2022 $ 597,485   $ 17 147,590   (984) 450,862  
Balance at end of period (in shares) at Dec. 31, 2022 16,951   16,951          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes $ 17,902   $ 1 17,901        
Issuance of common stock under employee stock compensation plans, net (in shares)     605          
Share-based compensation 25,743     25,743        
Unrealized net gain (loss) on available-for-sale securities, net of tax 167         167    
Final distribution of OmniAb 1,665     1,665        
Final tax impact of OmniAb distribution 5,797     5,797        
Net income (loss) 52,154           52,154  
Balance at end of period at Dec. 31, 2023 $ 700,913   $ 18 $ 198,696   $ (817) $ 503,016  
Balance at end of period (in shares) at Dec. 31, 2023 17,556   17,556